Transfer of L-α-acetylmethadol (LAAM) and L-α-acetyl-N-normethadol (norLAAM) by the perfused human placental lobule

Tatiana Nanovskaya, Sujal V. Deshmukh, Rachel Miles, Steve Burmaster, Mahmoud Ahmed

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The agonists buprenorphine and L-α-acetylmethadol (LAAM) were introduced as alternatives to methadone for treatment of the adult opiate addict. The direct and indirect effects of these drugs on normal fetal growth and development are currently under investigation in our laboratory. The goal of this report is to provide part of the data necessary to assess the safety of LAAM in treatment of the pregnant opiate addict. To achieve this goal, the technique of dual perfusion of placental lobule was utilized to determine the kinetics for transplacental transfer of LAAM and its effects on the viability and functional parameters of the tissue. LAAM is rapidly metabolized to the pharmacologically active norLAAM that was also included in this investigation. The two opiates were transfused at their plasma levels in patients under treatment, a concentration of 35 ng/ml. The drugs exhibited similar pharmacokinetic profiles, characterized by an initial phase of distribution into placental tissue followed by their low transfer to the fetal circuit. During the 4-h experimental period, the transfused tissue retained significant amounts of LAAM and norLAAM, and neither drug was metabolized. LAAM did not affect placental tissue viability and functional parameters. However, norLAAM caused a significant decrease in the release of human chorionic gonadotropin. At this time, it is unclear whether a similar effect for norLAAM may occur in vivo and, if so, what the consequences would be on its role in implantation and normal fetal growth and development.

Original languageEnglish (US)
Pages (from-to)205-212
Number of pages8
JournalJournal of Pharmacology and Experimental Therapeutics
Volume306
Issue number1
DOIs
StatePublished - Jul 1 2003

Fingerprint

Methadyl Acetate
Opiate Alkaloids
Fetal Development
Growth and Development
Pharmaceutical Preparations
Tissue Survival
Buprenorphine
Methadone
Chorionic Gonadotropin
Therapeutics
Pharmacokinetics
Perfusion
Safety

ASJC Scopus subject areas

  • Pharmacology

Cite this

Transfer of L-α-acetylmethadol (LAAM) and L-α-acetyl-N-normethadol (norLAAM) by the perfused human placental lobule. / Nanovskaya, Tatiana; Deshmukh, Sujal V.; Miles, Rachel; Burmaster, Steve; Ahmed, Mahmoud.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 306, No. 1, 01.07.2003, p. 205-212.

Research output: Contribution to journalArticle

@article{558ddceb63994ff9855f33db6b0db029,
title = "Transfer of L-α-acetylmethadol (LAAM) and L-α-acetyl-N-normethadol (norLAAM) by the perfused human placental lobule",
abstract = "The agonists buprenorphine and L-α-acetylmethadol (LAAM) were introduced as alternatives to methadone for treatment of the adult opiate addict. The direct and indirect effects of these drugs on normal fetal growth and development are currently under investigation in our laboratory. The goal of this report is to provide part of the data necessary to assess the safety of LAAM in treatment of the pregnant opiate addict. To achieve this goal, the technique of dual perfusion of placental lobule was utilized to determine the kinetics for transplacental transfer of LAAM and its effects on the viability and functional parameters of the tissue. LAAM is rapidly metabolized to the pharmacologically active norLAAM that was also included in this investigation. The two opiates were transfused at their plasma levels in patients under treatment, a concentration of 35 ng/ml. The drugs exhibited similar pharmacokinetic profiles, characterized by an initial phase of distribution into placental tissue followed by their low transfer to the fetal circuit. During the 4-h experimental period, the transfused tissue retained significant amounts of LAAM and norLAAM, and neither drug was metabolized. LAAM did not affect placental tissue viability and functional parameters. However, norLAAM caused a significant decrease in the release of human chorionic gonadotropin. At this time, it is unclear whether a similar effect for norLAAM may occur in vivo and, if so, what the consequences would be on its role in implantation and normal fetal growth and development.",
author = "Tatiana Nanovskaya and Deshmukh, {Sujal V.} and Rachel Miles and Steve Burmaster and Mahmoud Ahmed",
year = "2003",
month = "7",
day = "1",
doi = "10.1124/jpet.103.050690",
language = "English (US)",
volume = "306",
pages = "205--212",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

TY - JOUR

T1 - Transfer of L-α-acetylmethadol (LAAM) and L-α-acetyl-N-normethadol (norLAAM) by the perfused human placental lobule

AU - Nanovskaya, Tatiana

AU - Deshmukh, Sujal V.

AU - Miles, Rachel

AU - Burmaster, Steve

AU - Ahmed, Mahmoud

PY - 2003/7/1

Y1 - 2003/7/1

N2 - The agonists buprenorphine and L-α-acetylmethadol (LAAM) were introduced as alternatives to methadone for treatment of the adult opiate addict. The direct and indirect effects of these drugs on normal fetal growth and development are currently under investigation in our laboratory. The goal of this report is to provide part of the data necessary to assess the safety of LAAM in treatment of the pregnant opiate addict. To achieve this goal, the technique of dual perfusion of placental lobule was utilized to determine the kinetics for transplacental transfer of LAAM and its effects on the viability and functional parameters of the tissue. LAAM is rapidly metabolized to the pharmacologically active norLAAM that was also included in this investigation. The two opiates were transfused at their plasma levels in patients under treatment, a concentration of 35 ng/ml. The drugs exhibited similar pharmacokinetic profiles, characterized by an initial phase of distribution into placental tissue followed by their low transfer to the fetal circuit. During the 4-h experimental period, the transfused tissue retained significant amounts of LAAM and norLAAM, and neither drug was metabolized. LAAM did not affect placental tissue viability and functional parameters. However, norLAAM caused a significant decrease in the release of human chorionic gonadotropin. At this time, it is unclear whether a similar effect for norLAAM may occur in vivo and, if so, what the consequences would be on its role in implantation and normal fetal growth and development.

AB - The agonists buprenorphine and L-α-acetylmethadol (LAAM) were introduced as alternatives to methadone for treatment of the adult opiate addict. The direct and indirect effects of these drugs on normal fetal growth and development are currently under investigation in our laboratory. The goal of this report is to provide part of the data necessary to assess the safety of LAAM in treatment of the pregnant opiate addict. To achieve this goal, the technique of dual perfusion of placental lobule was utilized to determine the kinetics for transplacental transfer of LAAM and its effects on the viability and functional parameters of the tissue. LAAM is rapidly metabolized to the pharmacologically active norLAAM that was also included in this investigation. The two opiates were transfused at their plasma levels in patients under treatment, a concentration of 35 ng/ml. The drugs exhibited similar pharmacokinetic profiles, characterized by an initial phase of distribution into placental tissue followed by their low transfer to the fetal circuit. During the 4-h experimental period, the transfused tissue retained significant amounts of LAAM and norLAAM, and neither drug was metabolized. LAAM did not affect placental tissue viability and functional parameters. However, norLAAM caused a significant decrease in the release of human chorionic gonadotropin. At this time, it is unclear whether a similar effect for norLAAM may occur in vivo and, if so, what the consequences would be on its role in implantation and normal fetal growth and development.

UR - http://www.scopus.com/inward/record.url?scp=0038003002&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038003002&partnerID=8YFLogxK

U2 - 10.1124/jpet.103.050690

DO - 10.1124/jpet.103.050690

M3 - Article

VL - 306

SP - 205

EP - 212

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 1

ER -